首页> 外文期刊>Archives of disease in childhood >NETS1HD study: development of a Hirschsprung’s disease core outcome set
【24h】

NETS1HD study: development of a Hirschsprung’s disease core outcome set

机译:NETS1HD研究:开发Hirschsprung的疾病核心结局

获取原文
       

摘要

Objective The objective of this study was to develop a Hirschsprung’s disease (HD) core outcome set (COS). Methods Candidate outcomes were identified from a systematic review and stakeholder nomination. A three-phase Delphi process and consensus meeting were used to prioritise candidate outcomes based on scores assigned by stakeholder participants using a nine-point scale. In phases two and three, participants were shown graphical representations of their panel’s scores and all panels’ scores respectively for each outcome from the previous phase. After the third phase, outcomes prioritised by two or three panels were taken forward to the consensus meeting. The COS was formed from the 10 highest scoring outcomes meeting the threshold for inclusion (≥70% 7–9 and need for a permanent stoma, (10) enterocolitis. Conclusions This HD COS is formed of 10 outcomes deemed important by key stakeholders. Use of this COS in research will reduce outcome reporting heterogeneity and increase our ability to identify gold standard treatments for HD.
机译:目的这项研究的目的是开发一种Hirschsprung病(HD)核心结局(COS)。方法通过系统的审查和利益相关者的提名来确定候选结果。基于利益相关者参与者使用九点量表分配的分数,使用了一个分为三个阶段的Delphi过程和共识会议来对候选结果进行优先级排序。在第二阶段和第三阶段,分别为参与者显示了上一阶段每个结果的小组得分和所有小组得分的图形表示。在第三阶段之后,由两个或三个小组确定优先次序的结果将提交共识会议。 COS是由10个得分最高的结局组成的,这些结局符合纳入标准(≥70%7–9且需要永久性气孔,(10)小肠结肠炎。)结论该HD COS由关键利益相关者认为重要的10个结局组成。研究中使用这种COS的方法将减少结果报告异质性,并增强我们鉴定HD黄金标准疗法的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号